ghk-cu peptide benefits and safety GHK-Cu Copper Peptide Serum for

Daratumumab is approved as monotherapy and in combination with IMiD drugs (i.e., lenalidomide or pomalidomide based on the POLLUX, EQUULEUS, and APOLLO trials) or PIs (i.e., bortezomib or carfilzomib based on the CASTOR and CANDOR trials), plus dexamethasone for RRMM patients

Int J Chron Obstruct Pulmon Dis 17:405414 Lopez-Cano C, Ciudin A, Sanchez E, Tinahones FJ, Barbe F, Dalmases M et al (2022) Liraglutide improves forced vital capacity in individuals with type 2 diabetes: data from the randomized crossover LIRALUNG study

AOD 9604 is a peptide fragment derived from growth hormone

These recommendations rest on animal studies and practitioner observation rather than controlled human trials